In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that the next meeting of the Board of Directors is scheduled to be held on Tuesday, the 7th February 2023 to consider and approve the Audited Financial Results of the Company for the Quarter and nine months ended 31st December 2022 and declaration of Interim Dividend, if any, for the Financial Year 2022-2023. Further, pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's ‘Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons’, the Trading Window which is closed with effect from 01st January 2022 shall continue to close till the expiry of 48 hours from the date of financial results for Quarter and nine months ended 31st December 2022 are made public. Accordingly, the trading window shall reopen on the 10th February 2023.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |